circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

Yun Ling(Sun Yat-sen University), Chang Gong(Sun Yat-sen University)
Molecular Cancer
January 3, 2022
Cited by 91


Related Papers